These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1527046)
41. Structures of five sulfated hexasaccharides prepared from porcine intestinal heparin using bacterial heparinase. Structural variants with apparent biosynthetic precursor-product relationships for the antithrombin III-binding site. Tsuda H; Yamada S; Yamane Y; Yoshida K; Hopwood JJ; Sugahara K J Biol Chem; 1996 May; 271(18):10495-502. PubMed ID: 8631846 [TBL] [Abstract][Full Text] [Related]
42. New insights on the specificity of heparin and heparan sulfate lyases from Flavobacterium heparinum revealed by the use of synthetic derivatives of K5 polysaccharide from E. coli and 2-O-desulfated heparin. Nader HB; Kobayashi EY; Chavante SF; Tersariol IL; Castro RA; Shinjo SK; Naggi A; Torri G; Casu B; Dietrich CP Glycoconj J; 1999 Jun; 16(6):265-70. PubMed ID: 10579695 [TBL] [Abstract][Full Text] [Related]
43. Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4. Loo BM; Kreuger J; Jalkanen M; Lindahl U; Salmivirta M J Biol Chem; 2001 May; 276(20):16868-76. PubMed ID: 11278860 [TBL] [Abstract][Full Text] [Related]
44. Chemoenzymatic design of heparan sulfate oligosaccharides. Liu R; Xu Y; Chen M; Weïwer M; Zhou X; Bridges AS; DeAngelis PL; Zhang Q; Linhardt RJ; Liu J J Biol Chem; 2010 Oct; 285(44):34240-9. PubMed ID: 20729556 [TBL] [Abstract][Full Text] [Related]
45. Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains. Kato M; Wang H; Bernfield M; Gallagher JT; Turnbull JE J Biol Chem; 1994 Jul; 269(29):18881-90. PubMed ID: 8034644 [TBL] [Abstract][Full Text] [Related]
46. Modulation of proteoglycan synthesis by bovine vascular smooth muscle cells during cellular proliferation and treatment with heparin. Williams SP; Mason RM Arch Biochem Biophys; 1991 Jun; 287(2):386-96. PubMed ID: 1716868 [TBL] [Abstract][Full Text] [Related]
47. Disaccharide analysis of heparin and heparan sulfate using deaminative cleavage with nitrous acid and subsequent labeling with paranitrophenyl hydrazine. Kariya Y; Herrmann J; Suzuki K; Isomura T; Ishihara M J Biochem; 1998 Feb; 123(2):240-6. PubMed ID: 9538198 [TBL] [Abstract][Full Text] [Related]
48. Extended N-sulfated domains reside at the nonreducing end of heparan sulfate chains. Staples GO; Shi X; Zaia J J Biol Chem; 2010 Jun; 285(24):18336-43. PubMed ID: 20363743 [TBL] [Abstract][Full Text] [Related]
49. Characterization of the structure of antithrombin-binding heparan sulfate generated by heparan sulfate 3-O-sulfotransferase 5. Chen J; Liu J Biochim Biophys Acta; 2005 Sep; 1725(2):190-200. PubMed ID: 16099108 [TBL] [Abstract][Full Text] [Related]
50. Structure of heparan sulfate: identification of variable and constant oligosaccharide domains in eight heparan sulfates of different origins. Dietrich CP; Tersariol IL; Toma L; Moraes CT; Porcionatto MA; Oliveira FW; Nader HB Cell Mol Biol (Noisy-le-grand); 1998 May; 44(3):417-29. PubMed ID: 9620437 [TBL] [Abstract][Full Text] [Related]
51. Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2. Pye DA; Vivès RR; Hyde P; Gallagher JT Glycobiology; 2000 Nov; 10(11):1183-92. PubMed ID: 11087710 [TBL] [Abstract][Full Text] [Related]